Background Dose for Systemic Targeted Alpha Therapy
نویسندگان
چکیده
The phase 1 clinical trial of systemic Targeted Alpha Therapy for metastatic melanoma has shown that solid tumours can be regressed by alpha radiation. However, patient blood vessels and lymphocytes inevitably received a background radiation from non-targeted alpha decays in the blood circulation. To determine the toxicity of alpha particle to normal tissue capillaries and peripheral blood lymphocytes, capillary and lymphocyte models were established with Geant4 Monte Carlo microdosimetry technique. The specific energy deposited in a capillary endothelial cell nucleus or lymphocyte nucleus per radioactive decay and the cell survival rates were calculated for the source constrained in the vessel. The specific energy to lymphocytes depends on the type of blood vessels, with survival rates between 89% and 98%. The relationship between calculated specific energy and micronuclei data obtained in a clinical trial was determined, further establishing this technique as a biological dosimeter for Targeted Alpha Therapy. The 2 cGy dose to the capillary endothelial cell nucleus was found to be negligible. These results show that systemic Targeted Alpha Therapy is safe for the function of lymphocytes and normal tissue capillaries.
منابع مشابه
Systemic Targeted Alpha Radiotherapy for Cancer
Background: The fundamental principles of internal targeted alpha therapy for cancer were established many decades ago.The high linear energy transfer (LET) of alpha radiation to the targeted cancer cellscauses double strand breaks in DNA. At the same time, the short range radiation spares adjacent normal tissues. This targeted approach complements conventional external beam radiotherapy and ch...
متن کاملSystemic Targeted Alpha Radiotherapy for Cancer
BACKGROUND The fundamental principles of internal targeted alpha therapy forcancer were established many decades ago.The high linear energy transfer (LET) ofalpha radiation to the targeted cancer cellscauses double strand breaks in DNA. Atthe same time, the short range radiation spares adjacent normal tissues. This targeted approach complements conventional external beam radiotherapy and chemot...
متن کاملEnhancing and verification of dose in external radiation therapy using Gd nanoparticles as a theranostic agent: A Monte Carlo simulation study
Introduction: Theranostics, in particular, the use of radionuclides with the capability of simultaneous imaging and treatment has opened new horizons in personalized treatment planning of targeted radiation therapy. In this approach, positive beta or gamma emitters are required for imaging and alpha, beta and Auger electrons for treatment purpose. On the other hand, studies hav...
متن کاملTargeted alpha anticancer therapies: update and future prospects
Targeted alpha therapy (TAT) is an emerging option for local and systemic cancer treatment. Preclinical research and clinical trials show that alpha-emitting radionuclides can kill targeted cancer cells while sparing normal cells, thus reducing toxicity. (223)RaCl2 (Xofigo(®)) is the first alpha emitting radioisotope to gain registration in the US for palliative therapy of prostate cancer bone ...
متن کامل